Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Nov;9(11):3469-76.
doi: 10.1002/j.1460-2075.1990.tb07555.x.

Specific structural alteration of the influenza haemagglutinin by amantadine

R J Sugrue  1 , G Bahadur, M C Zambon, M Hall-Smith, A R Douglas, A J Hay
Affiliations

Specific structural alteration of the influenza haemagglutinin by amantadine

R J Sugrue et al. EMBO J. 1990 Nov.

Abstract

Amantadine hydrochloride specifically blocks the release of virus particles from H7 influenza virus infected cells. This appears to be the direct consequence of an amantadine induced change in the haemagglutinin (HA) to its low pH conformation. The effect is indirect and mediated via interaction of the drug with the M2 protein since mutants altered in this component alone are insensitive to amantadine. The timing of drug action, some 15-20 min after synthesis, and its coincidence with proteolytic cleavage indicates that the modifications to HA occur late during transport but prior to insertion into the plasma membrane. Reversal by mM concentrations of amines and 0.1 microM monensin indicates that amantadine action causes a reduction in intravesicular pH which triggers the conformational change in HA. We conclude, therefore, that the function of M2 inhibited by amantadine is involved in counteracting the acidity of vesicular compartments of the exocytic pathway in infected cells and is important in protecting the structural integrity of the acid-sensitive glycoprotein.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 1981 Jan 29;289(5796):366-73 - PubMed
    1. J Virol. 1978 Dec;28(3):710-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Feb;79(4):968-72 - PubMed
    1. J Gen Virol. 1982 May;60(Pt 1):61-6 - PubMed
    1. Mol Pharmacol. 1982 Jul;22(1):82-93 - PubMed